Press release
Peptide Therapeutics Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
The global peptide therapeutics market is projected to grow at a significant CAGR of around 9.0% during the forecast period. Peptides have gained a wide range of applications in medicine and biotechnology. In the last five years (2015-2019), the US Food Drug Administration (FDA) has authorized a total of 208 new drugs, 15 of which were peptides or peptide-containing molecules, which account for 7% of the total number of drugs. The primary factor that drives the peptide therapeutics market growth includes the potent and specific, yet safe, mode of action of peptides.To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/peptide-therapeutics-market
Besides the increased prevalence of diseases such as cancer also drives the global peptide therapeutics industry growth during the forecast period. Increased rate of mortality due to cancer has led to an increase in emphasis on the advancements of the drugs and products to combat the situation, which fuels the growth for the global peptide therapeutics market over the forecast period.
Based on the route of the delivery segment of the market, oral held the key share in the market. Oral delivery is the preferred route of drug administration, as the majority of patients see it as the most convenient way to take their drugs. Drugs taken by the oral route have the highest level of patient compliance due to the ease and simplicity of taking medications. Despite a large number of protein therapeutics being discovered each year, oral delivery continues to be a barrier. As a whole, protein and peptide drugs have low bioavailability when administered orally due to problematic barriers including gastrointestinal proteases, the epithelial barrier, and efflux pumps.
Further, the presence of the key players that provides suitable and proper drugs also drives the growth of the peptide therapeutics market during the forecast period. Players such as Amgen Inc., Eli Lilly and Co., Pfizer, Inc., Bristol-Myer Squibb Co., AstraZeneca Plc, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis International AG, Novo Nordisk A/S, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceuticals Industries Ltd., and others are some of the key players contributing to the growth of the market.
Global Peptide Therapeutics Market - Segmentation
By Route of Administration
• Oral
• Parenteral
By Application
• Cancer
• Gastrointestinal Disorders
• Central Nervous System Disorders
• Respiratory Disorders
• Others
A full report of Peptide Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/peptide-therapeutics-market
Global Peptide Therapeutics Market - Segmentation by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Amgen, Inc.
• AstraZeneca Plc
• Bachem Holding AG
• Bristol-Myers Squibb Co.
• CordenPharma InternationalGmbH
• Eli Lilly and Co.
• Hoffmann-La Roche Ltd.
• GlaxoSmithKline Plc
• Lonza Group AG
• Merck & Co. Inc.
• Novartis International AG
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/
https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031 here
News-ID: 3496027 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Peptide
Automated Microwave Peptide Synthesizer Market Innovation: Accelerating High-Thr …
The global Automated Microwave Peptide Synthesizer Market is witnessing robust growth as pharmaceutical companies, biotechnology firms, and research organizations increasingly adopt automated peptide synthesis technologies to accelerate drug discovery and development. Automated microwave peptide synthesizers have transformed peptide manufacturing by significantly reducing synthesis time while improving reaction efficiency, reproducibility, and product quality. As peptide-based therapeutics continue gaining prominence across modern medicine, demand for advanced synthesis platforms is expanding rapidly.
According to…
Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog
Peptide Express has launched an expanded catalog of 30+ research-grade peptides, each independently tested by third-party laboratories for 99%+ purity.
United States, 13th Jul 2026 - Peptide Express has announced the launch of its expanded catalog of research-grade peptides, built for laboratories, academic institutions, and independent researchers who require verifiable documentation of compound identity and purity.
The platform gives researchers access to more than 30 research compounds, each independently tested by third-party…
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg
Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity.
This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
